FDA Panel Supports Roche HPV Assay To Replace Pap As Primary Cervical Cancer Screen

The Microbiology Devices Panel provided unanimous support Roche’s submission to upgrade labeling for it cobas HPV test as a first-line, primary screen for cervical cancer.